New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 3, 2013
08:06 EDTBDXBecton Dickinson receives FDA clearance to market BD MAX StaphSR assay
BD Diagnostics, a segment of Becton Dickinson, announced it has received FDA clearance to market the BD MAX StaphSR Assay for use on the fully-automated BD MAX System. The assay, with eXTended Detection Technology, detects Staphylococcus aureus and methicillin-resistant Staphylococcus aureus DNA directly from nasal swabs, including mecA dropout mutants and new strains of MRSA that may not be detected by other assays.
News For BDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 3, 2016
06:14 EDTBDXBecton Dickinson backs FY16 adjusted EPS view of $8.37-$8.44, consensus $8.41
Subscribe for More Information
06:08 EDTBDXBecton Dickinson reports Q1 adjusted EPS $1.96, consensus $1.84
Reports Q1 revenue $2.99B, consensus $3.03B.
February 2, 2016
14:32 EDTBDXNotable companies reporting before tomorrow's open
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use